EPISODE · Feb 12, 2020 · 8 MIN
Bioxytran Inc. Discusses The Use of BXT-25 as a Late Stage Treatment for the Coronavirus
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Bioxytran, Inc. (BIXT)(“the Company”), a developmental stage biotechnology company. CEO of the Company, David Platt, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Bioxytran, Inc. (BIXT)(“the Company”), a developmental stage biotechnology company. CEO of the Company, David Platt, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Bioxytran Inc. Discusses The Use of BXT-25 as a Late Stage Treatment for the Coronavirus
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m